Sturm, Ruger & Company (NYSE:RGR) is lower in after hours trading after the company reported mixed financial results for Q4 and declared a quarterly dividend of $0.54 per share. Shares are down 4.91% at $65.01, with a 52-week range of $44.76 – $85.93. The firearms company reported Q4 earnings of $1.33 per share, compared with…
Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) are up 17.3%, positioning for a new 52-week high of $40.99 if the gains should hold into Wednesday. The stock just came off an evening-session halt after the company said it received FDA marketing approval for MONOVISC, a single injection supplement to synovial fluid of the osteoarthritic joint, used…
Pan American Silver (NASDAQ:PAAS) shares were down more than 3% Tuesday after the stock was downgraded to Sell from Neutral at Goldman Sachs, which lowered its price target to $10 from $15.22. PAAS was trading in a 52-week range of $14.66 to $15.04. Novo Nordisk (NYSE:NVO) shares were up about 5% after Bank of America…
After the markets closed on Monday, February 24, PRGX (NASDAQ:PRGX) reported fourth-quarter results that we believe are better than they appear at first blush. The headline results show a revenue shortfall of about $3 million relative to the consensus and a GAAP loss per share of $0.22, which are far below the consensus of about…
Chart Industries’ (NASDAQ:GTLS) overall fourth quarter 2013 EPS and awards were mostly in line with expectations; however, we believe this will be overshadowed by lower-than-expected 2014 EPS guidance ($3.10-$3.50 versus consensus $3.67) and more subdued market commentary regarding near-term growth prospects. There was already a somewhat downward bias to 2014 consensus EPS, the more cautious…
Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker…
